V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006725 | 330003480 | 1.7 | 89.4 | Neo-adjuvant (N) | 2014-08-22 | 2014-09-08 | Trial Unspecified | 02 | Y | 330003485 | TRIAL |
| 330006726 | 330003482 | 0 | 38.2 | Neo-adjuvant (N) | 2014-06-10 | 2014-07-08 | METHOTREXATE | Y | N | 330003495 | METHOTREXATE |
| 330006727 | 330003485 | 1.7 | 64.5 | Neo-adjuvant (N) | null | 2014-04-19 | Mifamurtide weeks 13-36 | N | null | 330003509 | MIFAMURTIDE |
| 330006728 | 330003486 | null | 75 | Palliative (P) | 2018-02-13 | 2018-02-15 | Trial Unspecified | N | null | 330003509 | TRIAL |
| 330006729 | 330003487 | 0 | 65.9 | Palliative (P) | 2013-10-12 | 2013-10-26 | CNS Medbl HR Cyclo+Vinc | N | N | 330003517 | TRIAL |
| 330006730 | 330003487 | 1.72 | 84 | Neo-adjuvant (N) | 2014-12-08 | 2014-12-08 | Trial Unspecified | N | null | 330003517 | TRIAL |
| 330006731 | 330003490 | 0 | 24.05 | Curative (C) | 2017-08-07 | 2017-12-18 | OST Mifamurtide | N | N | 330003521 | MIFAMURTIDE |
| 330006733 | 330003493 | 1.8 | 99.8 | Neo-adjuvant (N) | 2013-10-06 | 2013-12-17 | METHOTREXATE | N | Y | 330003528 | METHOTREXATE |
| 330006734 | 330012339 | 1.8 | 102.9 | Palliative (P) | 2017-07-21 | 2017-09-30 | Cisplatin | N | N | 330003531 | CISPLATIN |
| 330006735 | 330012339 | 1.61 | 55 | Curative (C) | 2018-01-22 | 2018-02-28 | EW EuroEwing 2012 Arm B VDC | null | null | 330003531 | TRIAL |
| 330006736 | 330003494 | null | 57.8 | Disease modification (D) | 2013-06-05 | 2013-06-27 | CNS Medbl HR Cyclo+Vinc | null | null | 330003535 | TRIAL |
| 330006737 | 330003495 | 1.76 | 69.4 | Neo-adjuvant (N) | null | 2014-05-19 | METHOTREXATE | N | N | 330003536 | METHOTREXATE |
| 330006738 | 330003496 | 1.85 | 75.4 | Curative (C) | 2016-11-11 | 2016-11-16 | OST Mifamurtide | 02 | Y | 330003549 | MIFAMURTIDE |
| 330006739 | 330003496 | 1.76 | 113 | Adjuvant (A) | 2015-02-13 | 2015-02-18 | Mifamurtide weeks 13-36 | N | Y | 330003549 | MIFAMURTIDE |
| 330006740 | 330003497 | 1.82 | 93.5 | Curative (C) | 2012-09-25 | 2013-09-08 | DOXORUBICIN | 02 | N | 330003558 | DOXORUBICIN |
| 330006741 | 330003497 | 1.72 | 100 | Adjuvant (A) | 2012-08-03 | 2015-04-12 | DOXORUBICIN | 02 | N | 330003558 | DOXORUBICIN |
| 330006742 | 330003498 | 1.45 | 62.6 | Neo-adjuvant (N) | 2016-11-28 | 2016-12-09 | MIFAMURTIDE | N | Y | 330003565 | MIFAMURTIDE |
| 330006745 | 330003501 | null | 59 | Palliative (P) | 2016-02-17 | 2016-02-29 | METHOTREXATE | N | Y | 330003572 | METHOTREXATE |
| 330006746 | 330003501 | 1.66 | 0 | Palliative (P) | 2014-07-18 | 2014-07-19 | OST Euramos 1 Closed Trial - A | N | null | 330003572 | DOXORUBICIN |
| 330006747 | 330003503 | null | null | Neo-adjuvant (N) | 2018-01-16 | 2018-02-10 | Cisplatin | N | null | 330003582 | CISPLATIN |
| 330006748 | 330003504 | 0 | 85.7 | Curative (C) | 2015-04-22 | 2015-04-23 | Trial Unspecified | N | Y | 330003585 | TRIAL |
| 330006749 | 330003505 | null | 64.6 | Palliative (P) | 2013-03-26 | 2013-03-26 | EW EuroEwing 2012 Arm B IE | Y | N | 330003592 | TRIAL |
| 330006750 | 330003506 | 1.66 | 78 | Adjuvant (A) | 2013-03-09 | 2013-03-22 | OST Mifamurtide | 02 | N | 330003597 | MIFAMURTIDE |
| 330006751 | 330003508 | 1.69 | 57.1 | Neo-adjuvant (N) | 2013-06-02 | 2013-06-23 | EW EuroEwing 2012 Arm B IE | N | N | 330003608 | TRIAL |
| 330006752 | 330003509 | 1.69 | 43.6 | null | 2016-04-27 | 2016-04-27 | Doxorubicin 75mg/m2 | null | N | 330003608 | DOXORUBICIN |
| 330006753 | 330003509 | 1.68 | 20.4 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-02 | Cisplatin 7 day | N | Y | 330003608 | CISPLATIN |
| 330006754 | 330003509 | 1.74 | 0 | null | 2015-01-19 | 2015-03-30 | Cisplatin 7 day | 2 | N | 330003608 | CISPLATIN |
| 330006755 | 330003509 | 1.73 | 97.3 | Neo-adjuvant (N) | 2014-08-17 | 2015-06-05 | OST Mifamurtide | N | N | 330003608 | MIFAMURTIDE |
| 330006756 | 330003511 | 1.64 | 72 | Palliative (P) | 2016-04-03 | 2017-05-12 | Mifamurtide weeks 13-36 | N | null | 330003634 | MIFAMURTIDE |
| 330006757 | 330003512 | 1.63 | 61 | Neo-adjuvant (N) | 2015-05-09 | 2015-05-22 | MIFAMURTIDE | null | Y | 330003635 | MIFAMURTIDE |
| 330006758 | 330003513 | 1.6 | 75 | Palliative (P) | 2014-06-11 | 2014-08-03 | METHOTREXATE | N | N | 330003636 | METHOTREXATE |
| 330006759 | 330003514 | 1.77 | 66.9 | Curative (C) | 2015-05-11 | 2015-06-05 | Cisplatin | N | N | 330003636 | CISPLATIN |
| 330006760 | 330003515 | null | 40.6 | Neo-adjuvant (N) | 2017-04-08 | 2017-06-25 | METHOTREXATE | N | Y | 330003642 | METHOTREXATE |
| 330006761 | 330003516 | null | 84.4 | Curative (C) | 2015-07-10 | 2015-07-10 | LI-1 TRIAL | null | null | 330003643 | TRIAL |
| 330006762 | 330003520 | 0 | 45.7 | Neo-adjuvant (N) | 2018-01-02 | 2018-01-16 | Trial Unspecified | N | N | 330003651 | TRIAL |
| 330006763 | 330003520 | 1.6 | 25.4 | Palliative (P) | 2017-09-28 | 2018-02-09 | Trial Unspecified | 02 | N | 330003651 | TRIAL |
| 330006764 | 330003520 | 1.73 | 57.8 | Palliative (P) | 2015-01-24 | 2015-02-20 | Trial Unspecified | null | N | 330003651 | TRIAL |
| 330006765 | 330003520 | 0 | 74.6 | Curative (C) | null | 2018-03-07 | MIFAMURTIDE | null | null | 330003651 | MIFAMURTIDE |
| 330006766 | 330003522 | 1.39 | 82.2 | Neo-adjuvant (N) | 2014-07-16 | 2014-10-15 | DOXORUBICIN | 02 | Y | 330003658 | DOXORUBICIN |
| 330006767 | 330007884 | 1.75 | 74.7 | Curative (C) | 2015-01-20 | 2015-01-31 | Mifamurtide weeks 13-36 | N | N | 330003677 | MIFAMURTIDE |
| 330006768 | 330003523 | 1.78 | 73.8 | Neo-adjuvant (N) | 2013-07-08 | 2013-08-29 | Cisplatin | N | N | 330003677 | CISPLATIN |
| 330006769 | 330003523 | 0 | 71.3 | Curative (C) | 2016-02-05 | 2016-02-06 | MIFAMURTIDE | N | N | 330003677 | MIFAMURTIDE |
| 330006770 | 330003524 | 1.86 | 89.4 | Curative (C) | 2013-03-28 | 2013-08-01 | Trial Unspecified | N | Y | 330003693 | TRIAL |
| 330006771 | 330003524 | 0 | 81 | Palliative (P) | 2017-09-24 | 2017-09-30 | OST Euramos 1 Closed Trial - IE | N | N | 330003693 | TRIAL |
| 330006772 | 330003525 | 1.09 | 108.2 | Palliative (P) | null | 2015-01-11 | DOXORUBICIN | Y | Y | 330003695 | DOXORUBICIN |
| 330006776 | 330003527 | 1.63 | 47 | Curative (C) | 2015-02-19 | 2015-08-06 | Mifamurtide weeks 1-12 | null | null | 330003708 | MIFAMURTIDE |
| 330006778 | 330007890 | 1.8 | 65.2 | Palliative (P) | null | 2017-03-31 | Trial Unspecified | N | N | 330003726 | TRIAL |
| 330006779 | 330010287 | null | 63.9 | null | 2016-04-10 | 2016-10-09 | MIFAMURTIDE | 1 | N | 330003728 | MIFAMURTIDE |
| 330006780 | 330003532 | 0 | null | Neo-adjuvant (N) | 2018-08-13 | 2018-09-15 | Cisplatin | 01 | N | 330003734 | CISPLATIN |
| 330006781 | 330003532 | null | 77.9 | Neo-adjuvant (N) | 2014-03-18 | 2014-03-22 | EW EuroEwing 2012 Arm A VAI | N | N | 330003734 | TRIAL |